Cwm, LLC Amphastar Pharmaceuticals, Inc. Transaction History

Cwm, LLC

$25.1 Billion
Q1 2025

A detailed history of Cwm, LLC transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Cwm, LLC holds 668 shares of AMPH stock, worth $16,559. This represents 0.0% of its overall portfolio holdings.

Number of Shares

668

Previous 1,154 42.11%

Holding current value

$16,559

Previous $43,000 55.81%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 01, 2025	SELL	$26.24 - $38.48 $12,752 - $18,701	-486 Reduced 42.11%	668 $19,000
Q4 2024 Feb 04, 2025	BUY	$36.84 - $53.4 $5,820 - $8,437	158 Added 15.86%	1,154 $43,000
Q3 2024 Oct 08, 2024	BUY	$36.99 - $50.09 $1,183 - $1,602	32 Added 3.32%	996 $48,000
Q2 2024 Jul 09, 2024	BUY	$38.65 - $43.48 $8,425 - $9,478	218 Added 29.22%	964 $39,000
Q1 2024 Apr 05, 2024	BUY	$42.85 - $63.45 $12,212 - $18,083	285 Added 61.82%	746 $33,000
Q4 2023 Feb 01, 2024	SELL	$44.49 - $62.93 $1,557 - $2,202	-35 Reduced 7.06%	461 $29,000
Q3 2023 Oct 11, 2023	SELL	$45.51 - $65.0 $682 - $975	-15 Reduced 2.94%	496 $23,000
Q1 2023 Apr 28, 2023	SELL	$27.99 - $37.92 $1,819 - $2,464	-65 Reduced 11.28%	511 $19,000
Q4 2022 Feb 01, 2023	SELL	$27.93 - $31.27 $27 - $31	-1 Reduced 0.17%	576 $16,000
Q3 2022 Oct 27, 2022	BUY	$27.56 - $37.75 $385 - $528	14 Added 2.49%	577 $16,000
Q2 2022 Jul 28, 2022	BUY	$29.79 - $42.29 $1,012 - $1,437	34 Added 6.43%	563 $20,000
Q1 2022 Apr 21, 2022	BUY	$22.96 - $36.45 $6,842 - $10,862	298 Added 129.0%	529 $19,000
Q4 2021 Jan 31, 2022	BUY	$18.14 - $23.29 $4,190 - $5,379	231 New	231 $5,000

Others Institutions Holding AMPH

# of Institutions

259

Shares Held

33.6M

Call Options Held

20.8K

Put Options Held

11.6K

View Full List

About Amphastar Pharmaceuticals, Inc.

Ticker AMPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,015,200
Market Cap $1.22B
Description
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...

More about AMPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.

Account